For good reason, many companies focus their legal and compliance work on matters that require immediate attention, like active litigation and pressing regulatory issues. But matters that come to the company’s attention before...more
Due diligence properly performed in connection with the purchase and sale of a health care entity is simply different—vastly so—than due diligence performed in other contexts. Failure to recognize this reality can lead to...more
9/26/2023
/ Anti-Kickback Statute ,
Billing ,
Buyers ,
Compliance ,
Department of Health and Human Services (HHS) ,
Due Diligence ,
False Claims Act (FCA) ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Medicare ,
Patients ,
PHI ,
Regulatory Requirements ,
Risk Management ,
Sellers ,
Sensitive Business Information ,
Sensitive Personal Information ,
Stark Law
On May 1, 2020, the Office of the National Coordinator for Health Information Technology (“ONC”) published its final rule, commonly referred to as the “Information Blocking Rule,” implementing certain provisions of the 21st...more